Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach

di Gasperini, Claudio, Ruggieri, Serena
Pubblicazione 2012

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets

di Gasperini, Claudio, Ruggieri, Serena, Pozzilli, Carlo
Pubblicazione 2010

Efficacy and safety of laquinimod in multiple sclerosis: current status

di Haggiag, Shalom, Ruggieri, Serena, Gasperini, Claudio
Pubblicazione 2013

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis

di Ruggieri, Serena, Tortorella, Carla, Gasperini, Claudio
Pubblicazione 2014

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod

di Gasperini, Claudio, Ruggieri, Serena, Mancinelli, Chiara Rosa, Pozzilli, Carlo
Pubblicazione 2013

Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis

di Corsetti, Marta, Ruocco, Gabriella, Ruggieri, Serena, Gasperini, Claudio, Battistini, Luca, Volpe, Elisabetta
Pubblicato in Int J Mol Sci (2019)

Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial

di Prosperini, Luca, Castelli, Letizia, De Giglio, Laura, Bonanno, Valeria, Gasperini, Claudio, Pozzilli, Carlo
Pubblicato in Neurotherapeutics (2019)

Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial

di Pozzilli, Carlo, Prosperini, Luca, Tommasin, Silvia, Gasperini, Claudio, Barbuti, Elena, De Giglio, Laura
Pubblicato in Ther Adv Neurol Disord (2021)

CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis

di Kunkl, Martina, Sambucci, Manolo, Ruggieri, Serena, Amormino, Carola, Tortorella, Carla, Gasperini, Claudio, Battistini, Luca, Tuosto, Loretta
Pubblicato in Cells (2019)

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study

di Sbardella, Emilia, Tomassini, Valentina, Gasperini, Claudio, Bellomi, Francesca, Cefaro, Luca Ausili, Morra, Vincenzo Brescia, Antonelli, Guido, Pozzilli, Carlo
Pubblicazione 2009

Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis

di Giorgio, Antonio, Battaglini, Marco, Gentile, Giordano, Stromillo, Maria Laura, Gasperini, Claudio, Visconti, Andrea, Paolillo, Andrea, De Stefano, Nicola
Pubblicato in Front Neurol (2020)

A Comprehensive Review on Copemyl(®)

di Annovazzi, Pietro, Bertolotto, Antonio, Brescia Morra, Vincenzo, Gasperini, Claudio, Montanari, Enrico, Navarra, Pierluigi, Patti, Francesco, Sormani, Maria Pia, Ghezzi, Angelo
Pubblicato in Neurol Ther (2017)

Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)

di Annovazzi, Pietro, Bertolotto, Antonio, Brescia Morra, Vincenzo, Gasperini, Claudio, Montanari, Enrico, Navarra, Pierluigi, Patti, Francesco, Pia Sormani, Maria, Ghezzi, Angelo
Pubblicato in Neurol Ther (2018)

Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients

di Capone, Alessia, Bianco, Manuela, Ruocco, Gabriella, De Bardi, Marco, Battistini, Luca, Ruggieri, Serena, Gasperini, Claudio, Centonze, Diego, Sette, Claudio, Volpe, Elisabetta
Pubblicato in Cells (2019)

Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus

di Filippi, Massimo, Capra, Ruggero, Centonze, Diego, Gasperini, Claudio, Patti, Francesco, Perini, Paola, Pozzilli, Carlo, Rocca, Maria A., Uccelli, Antonio, Trojano, Maria
Pubblicato in J Neurol (2021)

Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization

di De Stefano, Nicola, Giorgio, Antonio, Gentile, Giordano, Stromillo, Maria Laura, Cortese, Rosa, Gasperini, Claudio, Visconti, Andrea, Sormani, Maria Pia, Battaglini, Marco
Pubblicato in Ann Clin Transl Neurol (2021)

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

di Hupperts, Raymond, Lycke, Jan, Short, Christine, Gasperini, Claudio, McNeill, Manjit, Medori, Rossella, Tofil-Kaluza, Agata, Hovenden, Maria, Mehta, Lahar R, Elkins, Jacob
Pubblicato in Mult Scler (2016)

Switch Strategy from Direct Aspiration First Pass Technique to Solumbra Improves Technical Outcome in Endovascularly Treated Stroke

di Pampana, Enrico, Fabiano, Sebastiano, De Rubeis, Gianluca, Bertaccini, Luca, Stasolla, Alessandro, Pingi, Alberto, Cozzolino, Valeria, Mangiardi, Marilena, Anticoli, Sabrina, Gasperini, Claudio, Cotroneo, Enrico
Pubblicato in Int J Environ Res Public Health (2021)

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus

di Centonze, Diego, Rocca, Maria A., Gasperini, Claudio, Kappos, Ludwig, Hartung, Hans-Peter, Magyari, Melinda, Oreja-Guevara, Celia, Trojano, Maria, Wiendl, Heinz, Filippi, Massimo
Pubblicato in J Neurol (2021)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis

di Amadio, Susanna, Parisi, Chiara, Piras, Eleonora, Fabbrizio, Paola, Apolloni, Savina, Montilli, Cinzia, Luchetti, Sabina, Ruggieri, Serena, Gasperini, Claudio, Laghi-Pasini, Franco, Battistini, Luca, Volonté, Cinzia
Pubblicato in Front Immunol (2017)